Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

ATS/Fisher & Paykel Healthcare Research Grant in Nasal High Flow

American Thoracic Society

The focus of this research grant is proposals on respiratory support with nasal high flow therapy in adult patients. Patients must be in the hospital care during their involvement in the project.

Nasal high flow (NHF) therapy refers to a typical range from 20 to 70 L/min of heated, humidified gas delivered to the nares via purposely designed nasal cannula. Flow settings and fraction of delivered supplemental oxygen during the therapy vary depending on the patient’s level of compliance and severity of disease. There has been a recent rapid uptake in the use of NHF in acute care settings, primarily to treat hypoxemic respiratory failure, and the therapy has been extensively used around the world during the COVID-19 pandemic. Apart from efficient oxygenation due to the prevention of room air entrainment, NHF provides respiratory support that may be seen in the reduction of the breathing frequency and the work of breathing. Positive airway pressure and the reduction of re-breathing caused by the clearance of expired gas in the upper airways are believed to be the key mechanisms that may improve the ventilation efficiency during NHF. Saturation with water of heated gas maintains hydration of the airway surface liquid and preserves mucociliary function.

Fisher & Paykel Healthcare, in collaboration with the American Thoracic Society, seeks to offer a research award to investigators interested in studying these potential benefits of NHF in hospital patients. The prospective study could be aimed at better understanding the mechanisms of action of this therapy, or on achieving improvements in a variety of likely outcomes.

Applicants may request up to $50,000 for one year. NHF equipment and consumables will be provided for the study by Fisher & Paykel Healthcare at no cost. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution.

Specialties

Healthcare Delivery

Pulmonology

Medical Devices

Rhinology

Eligibility Requirements

Early-stage investigators interested in research on respiratory support with nasal high flow therapy in patients managed in the emergency department, intensive care unit, or ward.

Sponsor Details

Sponsor Institute/Organizations: American Thoracic Society

Address: American Thoracic Society 25 Broadway 4th Floor New York, NY 10004

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity

Grant

Final Deadline:

Dec 16, 2024

Funding Amount:

$50,000

Questions and Answers

Commonly asked questions about this funding opportunity from the host and other attendees.

Should I apply if I think my area of research is atypical for Research Program grantmaking?

Yes, please consider applying. The diversity of research among our awardees may surprise you. Grants are offered in all three pillars of the ATS: pulmonary, critical care, and sleep medicine. Grants are offered for basic, translational, and clinical science. Grants are offered in pediatric and adult medicine. Grants are available to international applicants. Grants are encouraged in basic, patient-oriented, and public health topics.

Can I submit a proposal that falls outside the current grant offerings?

No, the Research Program currently does not make grants outside our funding mechanisms.

What qualifies as an early-stage investigator?

ATS defines early-stage investigators as: within 12 years of terminal degree (e.g. MD, PhD). For the grant cycle launching in 2024, this means that you must have received your terminal degree no later than 2012. this requirement is not inclusive of sub-specialty training (e.g. fellowships). For example, if you received your MD in 2011 and completed your sub-specialty training in 2016, you would not be eligible for this award. exceptions may be considered for extenuating circumstances such as military service or parental leave. if you have extenuating circumstances not related to sub-specialty training, contact us before beginning a letter of intent or application.

May I apply if there are gaps in my work history?

Yes, if you have extenuating circumstances not related to sub-specialty training, contact us before beginning a letter of intent or application. Extenuating circumstances include factors such as family care responsibilities, illness, disability, and active-duty military service.

May I apply for a Research Program grant if I received one in the past?

Yes, you may apply but only if you are not a current Research Program grantee. Individuals who have received two Research Program grants are not eligible.

May I hold grants from other organizations?

Simultaneous submission of grants with scientific overlap to other funding agencies is allowed. However, if multiple grants are funded, then the applicant must notify the ATS within one month of formal award notification. A subcommittee of the Scientific Grant Review Committee (SGRC) will assess the degree of overlap. In the case of significant scientific overlap, the applicant will have to choose between the Research Program grant and the other grant. Budgetary overlap is not allowed.